139 related articles for article (PubMed ID: 22384634)
1. Clinical and histopathological factors in patients with cervical cancer allowing to identify candidates for less radical surgery.
Figat M; Zalewski K; Dańska-Bidzińska A; Rzepka J; Sobiczewski P; Gujski M; Bidziński M
Ginekol Pol; 2012 Jan; 83(1):16-21. PubMed ID: 22384634
[TBL] [Abstract][Full Text] [Related]
2. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
3. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
[TBL] [Abstract][Full Text] [Related]
4. A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
Kong TW; Piao X; Chang SJ; Paek J; Lee Y; Lee EJ; Ryu HS
Int J Gynecol Cancer; 2016 Jan; 26(1):184-91. PubMed ID: 26512782
[TBL] [Abstract][Full Text] [Related]
5. Patient-tailored conservative surgical treatment of invasive uterine cervical squamous cell carcinoma. A review.
Menczer J
Minerva Ginecol; 2013 Aug; 65(4):407-15. PubMed ID: 24051940
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of p53 expression in early stage cervical carcinoma treated by surgery.
Khunamornpong S; Siriaunkgul S; Manusirivithaya S; Settakorn J; Srisomboon J; Ponjaroen J; Thorner PS
Asian Pac J Cancer Prev; 2008; 9(1):48-52. PubMed ID: 18439073
[TBL] [Abstract][Full Text] [Related]
7. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
[TBL] [Abstract][Full Text] [Related]
9. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix.
Gauthier P; Gore I; Shingleton HM; Soong SJ; Orr JW; Hatch KD
Obstet Gynecol; 1985 Oct; 66(4):569-74. PubMed ID: 4047545
[TBL] [Abstract][Full Text] [Related]
10. Modified radical hysterectomy in the treatment of early squamous cervical cancer.
Magrina JF; Goodrich MA; Lidner TK; Weaver AL; Cornella JL; Podratz KC
Gynecol Oncol; 1999 Feb; 72(2):183-6. PubMed ID: 10021298
[TBL] [Abstract][Full Text] [Related]
11. The potential for less radical surgery in women with stage IA2-IB1 cervical cancer.
Bai H; Yuan F; Wang H; Chen J; Cui Q; Shen K
Int J Gynaecol Obstet; 2015 Sep; 130(3):235-40. PubMed ID: 26070225
[TBL] [Abstract][Full Text] [Related]
12. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer.
Frumovitz M; Sun CC; Schmeler KM; Deavers MT; Dos Reis R; Levenback CF; Ramirez PT
Obstet Gynecol; 2009 Jul; 114(1):93-99. PubMed ID: 19546764
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.
Gemer O; Lavie O; Gdalevich M; Eitan R; Mamanov E; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Meirovitz A; Shachar IB; Arie AB
Am J Clin Oncol; 2016 Feb; 39(1):37-42. PubMed ID: 25734407
[TBL] [Abstract][Full Text] [Related]
14. Mini-laparoscopic versus robotic radical hysterectomy plus systematic pelvic lymphadenectomy in early cervical cancer patients. A multi-institutional study.
Corrado G; Fanfani F; Ghezzi F; Fagotti A; Uccella S; Mancini E; Sperduti I; Stevenazzi G; Scambia G; Vizza E
Eur J Surg Oncol; 2015 Jan; 41(1):136-41. PubMed ID: 25468748
[TBL] [Abstract][Full Text] [Related]
15. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.
Rotman M; Sedlis A; Piedmonte MR; Bundy B; Lentz SS; Muderspach LI; Zaino RJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):169-76. PubMed ID: 16427212
[TBL] [Abstract][Full Text] [Related]
16. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.
Monk BJ; Wang J; Im S; Stock RJ; Peters WA; Liu PY; Barrett RJ; Berek JS; Souhami L; Grigsby PW; Gordon W; Alberts DS; ; ;
Gynecol Oncol; 2005 Mar; 96(3):721-8. PubMed ID: 15721417
[TBL] [Abstract][Full Text] [Related]
17. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
18. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
19. Which factors predict parametrial involvement in early stage cervical cancer? A Turkish multicenter study.
Kilic C; Cakir C; Yuksel D; Tokgozoglu N; Comert GK; Karalok A; Ureyen I; Turkmen O; Boyraz G; Tasci T; Tekin OM; Turan T
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():63-66. PubMed ID: 31675631
[TBL] [Abstract][Full Text] [Related]
20. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
